ACTIVE TUBERCULOSIS IN LEUKEMIA. MALIGNANT LYMPHOMA AND MYELOFIBROSIS.
D000477:Alkylating Agents; D000630:Aminopterin; D002066:Busulfan; D006689:Hodgkin Disease; D006801:Humans; D007938:Leukemia; D007945:Leukemia, Lymphoid; D007951:Leukemia, Myeloid; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D008466:Mechlorethamine; D015122:Mercaptopurine; D008727:Methotrexate; D009101:Multiple Myeloma; D009369:Neoplasms / Q000532:radiotherapy*; D010336:Pathology; D055728:Primary Myelofibrosis; D012509:Sarcoma; D014265:Triethylenemelamine; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary; D014520:Urethane
D000477:Alkylating Agents; D014520:Urethane; D008466:Mechlorethamine; D015122:Mercaptopurine; D014265:Triethylenemelamine; D002066:Busulfan; D000630:Aminopterin; D008727:Methotrexate
ALKYLATING AGENTS; AMINOPTERIN; BUSULFAN; HODGKIN'S DISEASE; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOCYTIC; LYMPHOMA; LYMPHOSARCOMA; MECHLORETHAMINE; MERCAPTOPURINE; METHOTREXATE; MULTIPLE MYELOMA; MYELOFIBROSIS; MYELOID METAPLASIA; NEOPLASM RADIOTHERAPY; PATHOLOGY; SARCOMA, RETICULUM CELL; TRIETHYLENE MELAMINE; TUBERCULOSIS; TUBERCULOSIS, PULMONARY; URETHANE